Clinical Scorecard: Managing Ocular Surface Disease

At a Glance

Key Highlights

• OSD is the most common reason for office visits among eyecare professionals.
• Patients may exhibit significant clinical pathology with few or no symptoms.
• Effective management requires a systematic diagnostic and targeted therapeutic approach.
• Ocular surgery can exacerbate OSD symptoms; preoperative optimization is essential.
• Patient education is crucial for treatment compliance and understanding of the condition.

Guideline-Based Recommendations

Diagnosis

• Utilize diagnostic technologies such as tear film hyperosmolarity tests and meibomian gland imaging.
• Conduct detailed ocular history including lifestyle, occupation, and systemic diseases.

Management

• Implement medical therapy to improve tear volume and composition, and reduce evaporation.
• Consider office procedures to restore meibomian gland function and reduce inflammation.

Monitoring & Follow-up

• Regular follow-up visits to assess symptom severity and treatment efficacy.

Risks

• Untreated OSD can lead to poor surgical outcomes and increased patient discomfort postoperatively.

Patient & Prescribing Data

Individuals with dry eye disease and related ocular surface disorders.

Chronic condition requiring ongoing management and patient education for effective treatment adherence.

Clinical Best Practices

• Educate patients on the importance of a healthy ocular surface for quality vision.
• Encourage compliance with treatment plans and set realistic expectations regarding timelines.
• Recognize and address ocular surface compromise prior to surgical procedures.

References

• TFOS DEWS II Definition and Classification Report
• International Workshop on Meibomian Gland Dysfunction